Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature.

Berger JS, Sallum RH, Katona B, Maya J, Ranganathan G, Xu Y, Mwamburi M.

Am Heart J. 2012 Aug;164(2):153-162.e5. doi: 10.1016/j.ahj.2012.04.001. Epub 2012 Jul 17. Review.

PMID:
22877800
[PubMed - indexed for MEDLINE]
2.

Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.

Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Fox KA, Granger CB, Jolly S, Rupprecht HJ, Widimsky P, Yusuf S; CURRENT-OASIS 7 Steering Committee.

Am Heart J. 2008 Dec;156(6):1080-1088.e1. doi: 10.1016/j.ahj.2008.07.026. Epub 2008 Nov 1.

PMID:
19033002
[PubMed - indexed for MEDLINE]
3.

A risk score to predict bleeding in patients with acute coronary syndromes.

Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW.

J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66. doi: 10.1016/j.jacc.2009.09.076.

PMID:
20513595
[PubMed - indexed for MEDLINE]
Free Article
4.

Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.

Bangalore S, Cohen DJ, Kleiman NS, Regev-Beinart T, Rao SV, Pencina MJ, Mauri L; EVENT Registry Investigators, Boston, MA.

Circ Cardiovasc Interv. 2011 Oct 1;4(5):463-73. doi: 10.1161/CIRCINTERVENTIONS.111.961912. Epub 2011 Oct 4.

PMID:
21972401
[PubMed - indexed for MEDLINE]
Free Article
5.

The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).

Amad H, Yan AT, Yan RT, Huynh T, Gore JM, Montalescot G, DeYoung JP, Gallo R, Rose B, Steg PG, Goodman SG; Canadian Global Registry of Acute Coronary Events (GRACE) Investigators.

Can J Cardiol. 2012 Jan-Feb;28(1):48-53. doi: 10.1016/j.cjca.2011.09.003. Epub 2011 Nov 23.

PMID:
22112683
[PubMed - indexed for MEDLINE]
6.

[Bleeding complications after treatment with clopidogrel and acetylsalicylic acid after acute coronary syndrome].

Kjaer J, Larsen CH, Poulsen TS, Møller JE, Mickley H.

Ugeskr Laeger. 2006 Sep 18;168(38):3209-14. Danish.

PMID:
17026894
[PubMed - indexed for MEDLINE]
7.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

PMID:
15461876
[PubMed - indexed for MEDLINE]
Free Article
8.

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.

Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR.

Ann Intern Med. 2005 Aug 16;143(4):241-50.

PMID:
16103468
[PubMed - indexed for MEDLINE]
10.

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson CM; ATLAS ACS-TIMI 46 study group.

Lancet. 2009 Jul 4;374(9683):29-38. doi: 10.1016/S0140-6736(09)60738-8. Epub 2009 Jun 17.

PMID:
19539361
[PubMed - indexed for MEDLINE]
11.

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

Warkentin AE, Donadini MP, Spencer FA, Lim W, Crowther M.

J Thromb Haemost. 2012 Apr;10(4):512-20. doi: 10.1111/j.1538-7836.2012.04635.x. Review.

PMID:
22257078
[PubMed - indexed for MEDLINE]
12.

[Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases].

Preobrazhenskiĭ DV, Sidorenko BA, Fettser DV, Batyraliev TA, Niiazova-Karben ZA, Besnili F.

Kardiologiia. 2010;50(5):73-6. Review. Russian.

PMID:
20831051
[PubMed - indexed for MEDLINE]
13.

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.

Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E.

J Am Coll Cardiol. 2008 May 27;51(21):2028-33. doi: 10.1016/j.jacc.2008.04.002.

PMID:
18498956
[PubMed - indexed for MEDLINE]
Free Article
14.

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.

Cohen M, Théroux P, Borzak S, Frey MJ, White HD, Van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F; ACUTE II Investigators.

Am Heart J. 2002 Sep;144(3):470-7.

PMID:
12228784
[PubMed - indexed for MEDLINE]
15.

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.

Jolly SS, Pogue J, Haladyn K, Peters RJ, Fox KA, Avezum A, Gersh BJ, Rupprecht HJ, Yusuf S, Mehta SR.

Eur Heart J. 2009 Apr;30(8):900-7. doi: 10.1093/eurheartj/ehn417. Epub 2008 Sep 26.

PMID:
18819961
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.

Han YL, Wang B, Li Y, Xu K, Wang SL, Jing QM, Wang ZL, Wang DM, Ma YY, Wang G.

Chin Med J (Engl). 2009 Apr 5;122(7):793-7.

PMID:
19493391
[PubMed - indexed for MEDLINE]
Free Article
18.

Characteristics, management and outcomes of patients with acute coronary syndrome and prior coronary artery bypass surgery: findings from the second Gulf Registry of Acute Coronary Events.

Al-Aqeedi R, Sulaiman K, Al Suwaidi J, Alhabib K, El-Menyar A, Panduranga P, Alshiekh-Ali A, Al Saif S.

Interact Cardiovasc Thorac Surg. 2011 Dec;13(6):611-8. doi: 10.1510/icvts.2011.274571. Epub 2011 Sep 13.

PMID:
21920933
[PubMed - indexed for MEDLINE]
Free Article
19.

Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GY.

Chest. 2008 Sep;134(3):559-67. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18.

PMID:
18641090
[PubMed - indexed for MEDLINE]
20.

High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

Parodi G, Marcucci R, Valenti R, Gori AM, Migliorini A, Giusti B, Buonamici P, Gensini GF, Abbate R, Antoniucci D.

JAMA. 2011 Sep 21;306(11):1215-23. doi: 10.1001/jama.2011.1332.

PMID:
21934054
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk